Stock Events

Stock Events

Mabion. 

zł8.58
1
-zł0.37-4.13% Today

Statistics

Day High
8.9
Day Low
8.5
52W High
11.8
52W Low
6.7
Volume
69,380
Avg. Volume
42,716
Mkt Cap
138.67M
P/E Ratio
8.09
Dividend Yield
-
Dividend
-

Earnings

4NovExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-9.18%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
138.04MRevenue
-12.67MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MAB.WA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen is a biotechnology company that develops and markets therapies for neurological and neurodegenerative diseases, competing in the biopharmaceutical sector similar to Mabion.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a global biotechnology firm that develops innovative human therapeutics, including in the oncology and inflammation sectors, directly competing with Mabion's therapeutic areas.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas similar to Mabion, particularly in the fields of oncology and viral diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is known for its innovative biopharmaceuticals in areas like oncology, competing directly with Mabion in the development of monoclonal antibodies.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that operates in various therapeutic areas, including those targeted by Mabion, making it a direct competitor in the biopharmaceutical market.
Merck
MRK
Mkt Cap214.76B
Merck is a global healthcare company that produces medicines, vaccines, biologic therapies, and animal health products, competing in similar therapeutic areas as Mabion.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines, directly competing with Mabion in various therapeutic areas.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses worldwide, with a strong focus on oncology and immunology, overlapping with Mabion's focus areas.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca operates in segments that include oncology, cardiovascular, renal, metabolism, and respiratory, competing with Mabion in the biopharmaceutical and oncology sectors.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a comprehensive healthcare firm that produces pharmaceuticals across a broad range of therapeutic areas, including those targeted by Mabion, making it a significant competitor.

About

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.
Show more...
CEO
Mr. Krzysztof Kaczmarczyk
Employees
244
Country
Poland
ISIN
PLMBION00016

Listings

WA
PL
MAB.WA
LSE
GB
0QGW.LSE
F
DE
272.F

0 Comments

Share your thoughts

FAQ

What is Mabion. stock price today?▼
The current price of MAB.WA is zł8.58 PLN — it has decreased by -4.13% in the past 24 hours. Watch Mabion. stock price performance more closely on the chart.
What is Mabion. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mabion. stocks are traded under the ticker MAB.WA.
Is Mabion. stock price growing?▼
MAB.WA stock has fallen by -6.84% compared to the previous week, the month change is a +5.28% rise, over the last year Mabion. has showed a -10.62% decrease.
What is Mabion. market cap?▼
Today Mabion. has the market capitalization of 138.67M
What is Mabion. revenue for the last year?▼
Mabion. revenue for the last year amounts to 138.04M PLN.
What is Mabion. net income for the last year?▼
MAB.WA net income for the last year is -12.67M PLN.
How many employees does Mabion. have?▼
As of April 02, 2026, the company has 244 employees.
In which sector is Mabion. located?▼
Mabion. operates in the Healthcare sector.
When did Mabion. complete a stock split?▼
Mabion. has not had any recent stock splits.
Where is Mabion. headquartered?▼
Mabion. is headquartered in Konstantynów Lódzki, Poland.